Bicycle Therapeutics Plc

Ownership Transactions Reported by 20 Insiders

Symbol
BCYC on Nasdaq
Industry
Pharmaceutical Preparations
Location
Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom

Insiders trading volume in the past year

Bicycle Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director, 10%+ Owner $382M Jun 17, 2024
Kate Bingham Director $32.7M Jul 13, 2021
Kevin Lee CHIEF EXECUTIVE OFFICER, Director $8.48M -$362K -4.09% Oct 3, 2024
Gregory Paul Winter Director $3.16M Jan 2, 2024
Michael Skynner Chief Technology Officer $2.07M -$110K -5.03% Oct 3, 2024
Alistair Milnes Chief Operating Officer $1.56M -$110K -6.55% Oct 3, 2024
Nicholas Keen Chief Scientific Officer $1.36M -$80.3K -5.59% Jul 3, 2024
Nigel Crockett Chief Business Officer $1.02M -$110K -9.7% Oct 3, 2024
Santiago Arroyo Chief Development Officer $683K Feb 6, 2024
Dominic Smethurst Chief Medical Officer $642K Jan 3, 2023
Pierre Legault Director $586K Jan 2, 2024
Lee Kalowski President and CFO $530K Apr 3, 2023
Travis Alvin Thompson Chief Accounting Officer $510K -$20.5K -3.86% Oct 3, 2024
Michael Charles Ferguson Hannay Chief Prod & Supply Chain Off $499K -$16.1K -3.13% Oct 3, 2024
Veronica GH Jordan Director $293K Jan 2, 2024
Richard N. Kender Director $293K Jan 2, 2024
Janice Bourque Director $293K Jan 2, 2024
Jose-Carlos Gutierrez-Ramos Director $293K Jan 2, 2024
Stephen H. Sands Director $210K Feb 20, 2024
Alethia Young Chief Financial Officer $210K Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Bicycle Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.